<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="emergency of international concern. The most common clinical manifestations of" exact="SARS-CoV-2 infection" post="are fever, cough, and dyspnea, however also muscle pain,"/>
 <result pre="in SARS-CoV and MERS-CoV infections (Mahallawi et al., 2018). Specifically," exact="SARS-CoV-2 infection" post="is characterized by persistent antigenic T cellsâ€™ activation leading"/>
 <result pre="patients treated with immunotherapy. For this latter group of patients," exact="SARS-CoV-2 infection" post="may represent a serious threat. In fact, the immune"/>
 <result pre="virus-specific CD4â€¯+â€¯T cells, showing features of exhausted lymphocytes. Patients with" exact="SARS-CoV-2 infection" post="have a markedly decreased number of NK and CD8â€¯+â€¯T"/>
 <result pre="interplay between immune system of oncologic patients receiving immunotherapy and" exact="SARS-CoV-2 infection" post="is extremely complex. What happens when a reinforced immune"/>
 <result pre="coronavirus infectionsJ. Pathol.235201518519525270030 GrivennikovS.I.GretenF.R.KarinM.Immunity, inflammation, and cancerCell140201088388920303878 GuanW.NiZ.LiangW.Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN. Engl. J. Med.202010.1056/NEJMoa2002032 GuoF.F.CuiJ.W.The role of tumor-infiltrating"/>
 <result pre="a risk assessment score for patients with cancer during the" exact="coronavirus disease 2019" post="pandemicEur. J. Cancer1352020475010.1016/j.ejca.2020.05.01732534244 JaziehA.R.AlenaziT.H.AlhejaziA.Outcome of oncology patients infected with"/>
 <result pre="of COVID-19Ann. Intern. Med.202010.7326/M20-1133 LambertiniM.TossA.PassaroA.Cancer care during the spread of" exact="coronavirus disease 2019" post="(COVID-19) in Italy: young oncologistsâ€™ perspectiveESMO Open202010.1136/esmoopen-2020-000759 LennonH.SperrinM.BadrickE.RenehanA.G.The obesity"/>
</results>
